UK-based pharma major AstraZeneca (LSE: AZN) has started construction on a new manufacturing site for small molecule drugs in ...

The drug maker on Tuesday announced a new 470,000-square-foot facility in Wilmington, Delaware, where it will make Keytruda, the company's immunotherapy treatment for different cancers. The plant ...

The global cholesterol API market is witnessing robust growth, driven by the expanding application of cholesterol-based raw materials across pharmaceuticals, biotechnology, cosmetics, and advanced ...

The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

Commerce officials approved an incentives package worth up to $13.1 million for the company, which plans to build a $700 million plant in the Wake County town. It's the latest drugmaker to target the ...

The biotechnology company announced in December plans to invest $1 billion to build a second drug substance manufacturing plant in Holly Springs, North Carolina. Amgen also has manufacturing ...

Dr Matthias Magoola, the founder and managing director of Dei Biopharma Ltd, has been awarded one of the continent’s top ...

Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot manufacturing facility in Holly Springs. The company expects to employ 420 ...

An age-old question about which came first, the chicken or the egg, won't matter for a biotech startup that aims ... has plans for a 130,000-square-foot plant in Jefferson County that would ...

The biotechnology company announced in December plans to invest $1 billion to build a second drug substance manufacturing plant in Holly Springs, North Carolina. Amgen also has manufacturing ...